These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2172922)

  • 1. [Pathogenesis and prevention of gastrointestinal complications following transcatheter arterial embolization].
    Tsuchigame T; Takahashi M; Watanabe O; Yoshimatsu S; Yamashita Y; Uozumi H; Ueno S; Hirota Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jul; 50(7):798-803. PubMed ID: 2172922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of response to naproxen in patients with hepatocellular carcinoma who developed fever following transcatheter arterial embolization.
    Akaji H; Hagino M; Inoue K; Hirota N; Nakamura H
    Radiat Med; 1990; 8(6):227-9. PubMed ID: 1965557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rupture of hepatocellular carcinoma after transcatheter arterial embolization: an unusual case.
    Sakamoto Y; Kita Y; Takayama T; Kawauchi N; Minagawa M; Makuuchi M
    Hepatogastroenterology; 1999; 46(25):453-6. PubMed ID: 10228840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of partial splenic embolization (PSE) in hepatocellular carcinomas showing a risk of gastrointestinal bleeding after transcatheter arterial embolization (TAE)].
    Ohmoto K; Yamamoto R; Yamamoto S; Ideguchi S; Saito I; Wada A; Takatori K; Ohumi T; Hino K; Hirano Y
    Gan No Rinsho; 1989 May; 35(6):690-5. PubMed ID: 2542638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute pancreatitis after transcatheter arterial embolization (TAE) for hepatocellular carcinoma.
    Kishimoto W; Nakao A; Takagi H; Hayakawa T
    Am J Gastroenterol; 1989 Nov; 84(11):1396-9. PubMed ID: 2479261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complication of therapeutic transcatheter hepatic artery embolization for hepatoma--case of developing an extensive acute gastric ulcer].
    Matsuura T; Tsukamoto Y; Nakata H; Nakayama T; Shirakawa F; Okazaki I; Suzuki H
    Gan No Rinsho; 1983 Feb; 29(2):A-11, 164-7. PubMed ID: 6308299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of caerulein in suppressing post-TAE complications of the gallbladder].
    Akamatsu K; Miyauchi S; Yasuhara Y; Mogami H; Nishimura N; Ohshima K; Ohta Y
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1094-9. PubMed ID: 3032112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute gastric lesions following transcatheter arterial embolization of hepatic malignancies].
    Tsuchigame T; Takahashi M; Bussaka H; Miyawaki M; Fukui K; Yasunaga T; Nanakawa S; Miyao M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Dec; 44(12):1501-7. PubMed ID: 6099540
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacterial infections associated with hepatic arteriography and transarterial embolization for hepatocellular carcinoma: a prospective study.
    Chen C; Tsang YM; Hsueh PR; Huang GT; Yang PM; Sheu JC; Lai MY; Chen PJ; Chen DS
    Clin Infect Dis; 1999 Jul; 29(1):161-6. PubMed ID: 10433580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroduodenal lesions after transcatheter arterial chemo-embolization in patients with hepatocellular carcinoma.
    Hirakawa M; Iida M; Aoyagi K; Matsui T; Akagi K; Fujishima M
    Am J Gastroenterol; 1988 Aug; 83(8):837-40. PubMed ID: 2839979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rupture of hepatocellular carcinoma following transcatheter arterial embolization.
    Nakao N; Kotake M; Miura K; Ohnishi M; Miura T
    Radiat Med; 1988; 6(4):147-9. PubMed ID: 2850593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter partial splenic arterial embolization in patients with hypersplenism: a clinical evaluation as supporting therapy for hepatocellular carcinoma and liver cirrhosis.
    Hirai K; Kawazoe Y; Yamashita K; Kumagai M; Tanaka M; Sakai T; Inoue R; Eguchi S; Majima Y; Abe M
    Hepatogastroenterology; 1986 Jun; 33(3):105-8. PubMed ID: 3017829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum interleukin 6 as a predicator of the therapeutic effect and adverse reactions after transcatheter arterial embolization.
    Yamazaki H; Nishimoto N; Oi H; Matsushita M; Ogata A; Shima Y; Inoue T; Tang JT; Yoshizaki K; Kishimoto T
    Cytokine; 1995 Feb; 7(2):191-5. PubMed ID: 7780039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transcatheter arterial embolization of unresectable hepatocellular carcinoma: does selective treatment improve outcome?].
    Ganaha F; Koyama K; Sadaoka S; Yamada T; Kanehira C; Fukuda K
    Nihon Igaku Hoshasen Gakkai Zasshi; 2005 Jul; 65(3):240-7. PubMed ID: 16119785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in esophageal variceal pressure after transcatheter arterial embolization for hepatocellular carcinoma.
    Okada K; Koda M; Murawaki Y; Kawasaki H
    Endoscopy; 2001 Jul; 33(7):595-600. PubMed ID: 11473331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of transcatheter arterial infusion chemotherapy and transcatheter arterial embolization in 132 patients with primary hepatocellular carcinoma].
    Shi Z; Guo Y; Liu D
    Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):211-3. PubMed ID: 11776839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma.
    Maluccio MA; Covey AM; Porat LB; Schubert J; Brody LA; Sofocleous CT; Getrajdman GI; Jarnagin W; Dematteo R; Blumgart LH; Fong Y; Brown KT
    J Vasc Interv Radiol; 2008 Jun; 19(6):862-9. PubMed ID: 18503900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ruptured hepatocellular carcinoma following transcatheter arterial embolization: a case report].
    Yamashita Y; Shinzato J; Saito R; Korogi Y; Takahashi M; Sakai M
    Rinsho Hoshasen; 1986 Sep; 31(9):1053-5. PubMed ID: 3023721
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatic perfusion index in evaluating treatment effect of transcatheter hepatic artery embolization in patients with hepatocellular carcinoma.
    Lin WY; Wang SJ; Yeh SH
    Neoplasma; 1995; 42(2):89-92. PubMed ID: 7617083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The movement of antineoplastic solutions in transcatheter hepatic arterial embolization].
    Tsuda M; Yamada R; Sato M; Tanaka K; Nomura S; Tsuzi T; Terada M; Shioyama Y; Maeda M; Kishi K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 May; 50(5):504-11. PubMed ID: 2167464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.